Consistent with these reports, we observed obvious c-Cbl/Grb2-dependent EGFR ubiquitination in tumor cells exhibiting low levels of hypoxia-induced EGFR activation (HN4 and HN6 cells). The gene discussed is CBL; the disease is neoplasm.